• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

Development of tumor-targeted therapy using measles virus-displayed antibody library

Research Project

  • PDF
Project/Area Number 22659227
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeSingle-year Grants
Research Field General surgery
Research InstitutionThe University of Tokyo

Principal Investigator

NAKAMURA Takafumi  東京大学, 医科学研究所, 特任准教授 (70432911)

Project Period (FY) 2010 – 2011
Keywords実験外科学
Research Abstract

We have successfully developed a pseudoreceptor system which allows rescue and propagation of retargeted viruses displaying single chain antibody fragments(scFvs). Thus, receptor choice is not a significant limitation for targeting measles viruses and the use of single chain antibodies for targeting potentially allows us to redirect the virus against any chosen cellular receptor.
In this study, we try to develop measles virus-displayed scFv library(virobody library) using the technology for identification of tumor-specific scFv. Human A549 lung, or BxPC-3 pancreatic carcinoma cells were infected with virobody library at an MOI of 0. 01 to 1, one hour later the cells were washed with Opti-MEM medium(Invitrogen) four times. 2 to 5 days after infection, propagated viruses were harvested by repeated freeze-thaw cycles from the GFP-positive infected cells. The biopanning was repeated several times, and finally the tumor-targeted measles virus was cloned from the GFP-positive infected cells. The cDNA encoding scFv from the viral RNA genome was amplified by RT-PCR for sequence analysis. However, the identified scFvs were not functional as a tumor-specific antibody. We have assumed that the diversity of measles virus-displayed scFv library is not sufficient enough to identify tumor-specific scFvs. To address this question, not traditional ligation method but Gateway[○! R] Technology-based cloning method(Invitrogen) was used for generation of plasmid library. Various kind of scFvs were incorporated into the C terminus of a receptor-blind H gene in a full-length cDNA clone of Edmonston measles virus. Furthermore, infectious scFv-displaying measles viruses were rescued from the full-length cDNA clones using helper vaccinia virus expressing T7 RNA polymerase. These modifications dramatically increased the diversity of measles virus-displayed scFv library.

  • Research Products

    (6 results)

All 2012 2011

All Journal Article (2 results) Presentation (4 results)

  • [Journal Article] Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma2012

    • Author(s)
      Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y, Okazaki T, Marumoto T, Takahashi A, Takayama K, Nakanishi Y, Shimizu H and Tani K.
    • Journal Title

      Cancer Res

      Volume: 72 Pages: 2609-2621

  • [Journal Article] MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy2011

    • Author(s)
      Hikichi M, Minoru Kidokoro M, Haraguchi T, Iba H, Shida H, Tahara H and Nakamura T
    • Journal Title

      Molecular Therapy

      Volume: 19 Pages: 1107-1115

  • [Presentation] MicroRNA Targeting of Oncolytic Viruses for cancer therapy2011

    • Author(s)
      Takafumi Nakamura.
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-04
  • [Presentation] MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy2011

    • Author(s)
      Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida, Hideaki Tahara and Takafumi Nakamura.
    • Organizer
      The International Union of Microbiological Societies 2011 Congress
    • Place of Presentation
      札幌
    • Year and Date
      2011-09-12
  • [Presentation] Development of tumor-targeting vaccinia viruses as novel oncolytic agents2011

    • Author(s)
      Takafumi Nakamura, Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida and Hideaki Tahara.
    • Organizer
      The 17th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      福岡
    • Year and Date
      2011-07-17
  • [Presentation] Enhancing therapeutic index of oncolytic vaccinia virus through combining micro RNA regulation and thymidine kinase deletion2011

    • Author(s)
      Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida, Hideaki Tahara and Takafumi Nakamura.
    • Organizer
      The 14th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Seattle, USA
    • Year and Date
      2011-05-20

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi